NCR2 and thyroid cancer: Prostaglandin E2 secreted by thyroid cancer cells inhibits expression of the NK-cell-activating receptors NKp44 and NKp30 and death receptor tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), resulting in suppressed NK cytotoxic function [47,58].